Mizuho Securities analyst Difei Yang raised the price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

NovoCure Ltd. (NVCR) PT Raised to $59 at WedbushMarch 1, 2019 11:24 AM